Chronic Expanding Hematoma Complicated by Life Threatening Hemoptysis and Respiratory Arrest-A Case Report
Abstract
Chronic expanding hematoma (CEH) is a rare, indolent entity mostly linked to prior tuberculosis, thoracic surgery or trauma, with gradual long-term enlargement and potentially fatal complications. We present a 73-year-old Nepalese male without classic predisposing risk factors, presenting with mild hemoptysis in 2017 and a large right pleural hematoma on computed tomography (CT). He declined surgical evacuation and later developed progressive hematoma expansion and subsequent life-threatening hemoptysis complicated by type 2 respiratory failure and suspected bronchopleural fistula in 2025. He was deemed inoperable, failed conservative management and succumbed to nosocomial pneumonia. Post-mortem histology confirmed CEH with dense fibrous tissue and organized blood clot. This case highlights early recognition and surgical intervention as critical for CEH, even in patients without antecedent thoracic insult.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.